| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |